MHRA is considering reclassification of Aquiette 2.5mg tablets as pharmacy medicine
The Medicines and Healthcare Products Regulatory Agency (MHRA) is considering the reclassification of Aquiette 2.5mg tablet contains oxybutynin hydrochloride that is used to treat...